|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||68.12 - 69.54|
|52 Week Range||52.51 - 80.71|
|PE Ratio (TTM)||19.75|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Stocks that moved substantially or traded heavily on Tuesday: Qualcomm Inc., down $3.11 to $59.70 President Donald Trump blocked Broadcom's effort to buy the rival chipmaker, citing national security concerns. ...
This could indicate that investors who seek to profit from falling equity prices are not currently targeting DVA. Over the last one-month, outflows of investor capital in ETFs holding DVA totaled $16.83 billion.
US not-for-profit hospitals will face greater competition, risk of volume declines and margin erosion as the nation's largest commercial health insurers aggressively pursue growth strategies, Moody's Investors ...
Flush with $4.9 billion in cash from the pending sale of its medical group and as much as $130 million in expected benefits from federal tax reform, DaVita Inc. CEO Kent Thiry said Tuesday that the company will look to repurchase shares, grow its kidney-care business and make “a limited number of investments” in other health-care companies. The comments came during a quarterly earnings call — the Denver-based kidney-care provider’s first since it announced the sale of its disappointing managed-care unit, DaVita Medical Group, in December to Optum. Thiry told the Denver Business Journal the day after the sale announcement that the company will look at the possible acquisition of companies in other areas of health care andt, already had begun looking at opportunities that it could integrate into its existing divisions.
On a per-share basis, the Denver-based company said it had net income of $1.64. Earnings, adjusted for one-time gains and costs, were 92 cents per share. The results exceeded Wall Street expectations. ...
On Tuesday, DaVita HealthCare (NYSE: DVA ) will release its latest earnings report. Here is Benzinga's outlook for the company. Earnings and Revenue Analysts expect DaVita HealthCare earnings of 94 cents ...
If there could be a health insurance superstore, it would probably be UnitedHealth Group Inc (NYSE:UNH). Through both organic operations and acquisitions, it now has a stronghold on many aspects of health insurance and associated businesses throughout the country. Most people think of UNH stock as simply being a health insurance provider. OptumHealth was purchased by UNH stock some time ago.
UnitedHealth Group’s Optum health services unit is now in half of the 75 U.S. markets executives targeted for expansion.
UnitedHealth’s quarterly profit beat analysts’ expectations and the health insurer raised its yearly outlook, as revenue from both its health care and health care services businesses increased.
DaVita (DVA) collaborates with Epic to introduce electronic health record facility for patients, reduce costs and enhance healthcare.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to DaVita, Inc. Here are 5 ETFs with the largest exposure to DVA-US. Comparing the performance and risk of DaVita, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
DaVita Inc. will pay $63.7 million to settle a whistle-blower lawsuit that alleged that the Denver-based company’s pharmaceutical division improperly billed the federal government for medications that were not used by patients and that it paid financial inducements to beneficiaries in violation of the federal anti-kickback laws. Two former DaVita employees also filed a whistle-blower lawsuit in U.S. District Court in northern Texas in 2016. This latest settlement follows DaVita agreeing to pay $389 million in 2014 to settle anti-kickback allegations surrounding joint ventures made with nephrologists and agreeing to pay $495 million in 2015 on a whistle-blower settlement regarding its billing over certain drugs that were only partially dispensed.